Rewarding Research
Refer-a-Friend
Contact The MEU
Facebook-f X-twitter Linkedin-in Instagram Youtube Tiktok

Current studies

Our Studies are currently paying up to £6000 - Call 0161 946 4059 for more information!!!

Do you have BOTH Asthma & COPD?

Study Type: Asthma
  • Varied
  • 18-75
  • Gender: Male & Female
Register Your Interest

Ulcerative Colitis – 1 Month

Study Type: Ulcerative Colitis
  • 1 Month
  • 18-75
  • Gender: Male & Female
Register Your Interest

Asthma – 2 Months

Study Type: COPD
  • 2 Months
  • 18-65
  • Gender: Male & Female
Register Your Interest

COPD – 3.5 Months

Study Type: COPD
  • 3.5 Months
  • 40-80
  • Gender: Male & Female
Register Your Interest

COPD – 18 Months

Study Type: COPD
  • 18 Months
  • 40-80
  • Gender: Male & Female
Register Your Interest

COPD – 10 Months

Study Type: COPD
  • 10 Months
  • 40-75
  • Gender: Male & Female
Register Your Interest

Idiopathic Pulmonary Fibrosis (IPF) – 6 Months

Study Type: Idiopathic Pulmonary Fibrosis
  • 6 Months
  • 18-55
  • Gender: Male & Female
Register Your Interest

Inflammatory Bowel Disease

Study Type: Inflammatory Bowel Disease

Up to £3,000

  • Varied
  • 18-75
  • Gender: Male & Female
Register Your Interest

Idiopathic Pulmonary Fibrosis (IPF) – 8 Weeks

Study Type: Idiopathic Pulmonary Fibrosis

TBC

  • 4-8 Weeks
  • 18+
  • Gender: Male & Female
Register Your Interest

An IQVIA Business

Contact Us

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations. Learn more at www.iqvia.com. 

Contact us…

The Medicines Evaluation Unit

The Langley Building

Southmoor Road

Wythenshawe Hospital

Manchester

M23 9QZ

T: 0800 655 6553

E: [email protected]